REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 144 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,972 | -56.3% | 695 | -3.5% | 0.00% | – |
| Q2 2023 | $18,223 | +86676.2% | 720 | +9.1% | 0.00% | – |
| Q1 2023 | $21 | +2000.0% | 660 | +1000.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 60 | +15.4% | 0.00% | – |
| Q3 2022 | $1,000 | -90.0% | 52 | -93.1% | 0.00% | – |
| Q4 2021 | $10,000 | -88.2% | 750 | -75.4% | 0.00% | -100.0% |
| Q3 2021 | $85,000 | -5.6% | 3,050 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $90,000 | +5.9% | 3,050 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $85,000 | +157.6% | 3,050 | +165.2% | 0.00% | – |
| Q4 2020 | $33,000 | -43.1% | 1,150 | -50.0% | 0.00% | – |
| Q3 2020 | $58,000 | +16.0% | 2,300 | +11.9% | 0.00% | – |
| Q2 2020 | $50,000 | +92.3% | 2,055 | +17.6% | 0.00% | – |
| Q1 2020 | $26,000 | -7.1% | 1,748 | 0.0% | 0.00% | – |
| Q4 2019 | $28,000 | -88.8% | 1,748 | -90.9% | 0.00% | -100.0% |
| Q3 2019 | $251,000 | – | 19,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |